Tumor necrosis factor-alpha alters the modulatory effects of mesenchymal stem cells on osteoclast formation and function.
Tumor necrosis factor-alpha alters the modulatory effects of mesenchymal stem cells on osteoclast formation and function.
复制标题
DOI:
10.1089/scd.2009.0021
复制
发表时间:
2009-12
影响因子:
4
通讯作者:
Heng Zhu;Xiao-Xia Jiang;Zi-Kuan Guo;Hong Li;Yong-feng Su;Hui-yu Yao;Xiao-Yan Wang;Xiusen Li;Ying Wu;Yuanlin Liu;Yi Zhang;N. Mao
中科院分区:
文献类型:
--
作者:
Heng Zhu;Xiao-Xia Jiang;Zi-Kuan Guo;Hong Li;Yong-feng Su;Hui-yu Yao;Xiao-Yan Wang;Xiusen Li;Ying Wu;Yuanlin Liu;Yi Zhang;N. Mao
Mesenchymal stem cells (MSCs) are characterized by their hematopoiesis-supporting and immunosuppressive capacity, while osteoclasts are main cell components in the endosteal hematopoietic stem cell niche and pivotal players in osteoimmunology. To clarify the association of these 2 kinds of cells, mouse CD11b(+) monocytes were cultured onto MSC layers in the presence or absence of macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-kappaB ligand (RANKL). The results showed that MSCs independently supported osteoclast development and this effect was enhanced by M-CSF and RANKL. Interestingly, tumor necrosis factor-alpha (TNF-alpha)-stimulated MSCs turned to inhibit osteoclast formation and protect tusk slices from osteoclastic resorption. Real-time PCR and ELISA assays demonstrated that osteoprotegerin expression at both mRNA and protein levels in TNF-alpha-stimulated MSCs was up-regulated, at least partially by activating the mitogen-activated protein kinase pathway. Furthermore, TNF-alpha-stimulated MSCs maintained their immunophenotypic, multipotential differentiation and immunosuppressive characteristics. Moreover, MSCs treated with synovial fluid from rheumatoid arthritis patients modulated osteoclast generation in close relation with the TNF-alpha levels. This study suggests that MSCs exhibit dual modulatory function on osteoclasts and the result might shed light on understanding the involvement of MSCs in the inflammatory diseases.